Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Li-Fraumeni syndrome]

T Frebourg1

  • 1Laboratoire de génétique moléculaire, Hôpital Charles-Nicolle, Centre hospitalo-universitaire de Rouen, France.

Bulletin Du Cancer
|July 1, 1997
PubMed
Summary

Li-Fraumeni syndrome is a genetic disorder increasing cancer risk, often diagnosed by identifying p53 gene mutations. Early detection through molecular testing aids in diagnosing this hereditary cancer predisposition syndrome.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression.

Molecular psychiatry·2016
Same author

Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort.

Journal of medical genetics·2015
Same author

SORL1 rare variants: a major risk factor for familial early-onset Alzheimer's disease.

Molecular psychiatry·2015

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Context:

  • Li-Fraumeni syndrome (LFS) is an autosomal dominant disorder.
  • It confers a high lifetime risk for a broad spectrum of cancers, including sarcomas, breast, brain, and adrenocortical carcinomas.
  • Cancers typically manifest in childhood and young adulthood.

Purpose:

  • To describe the genetic basis of Li-Fraumeni syndrome.
  • To outline diagnostic criteria for suspecting LFS.
  • To highlight the role of germline p53 mutations in LFS diagnosis.

Summary:

  • Germline mutations in the tumor suppressor gene p53 are identified in about 50% of LFS families.
  • These mutations are frequently missense mutations within the p53 DNA-binding domain (exons 5-8).
  • Functional assays analyzing p53 transcriptional activity in yeast can detect these inactivating mutations.

Impact:

  • Molecular identification of germline p53 mutations provides a definitive diagnosis for LFS.
  • This diagnosis has significant implications for genetic counseling and cancer surveillance in affected families.
  • Understanding the genetic underpinnings of LFS facilitates targeted screening and management strategies.

Related Experiment Videos